| Patents for A61P 41 - Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution (3,707) |
|---|
| 04/29/2008 | US7365170 Reagents for regulation of metabolic events, such as those mediated by adiponectin and adiponectin agonists. The invention also provides screening assays for identification of biologically active agents, diagnostic and therapeutic agents |
| 04/29/2008 | US7364757 Methods of treating vascular disease |
| 04/24/2008 | US20080096948 Serotonin antagonist compositions and methods for the local inhibition of pain and inflammation |
| 04/23/2008 | CN101164617A Combination drug therapy for reducing scar tissue formation |
| 04/23/2008 | CN101164530A Aqueous solution containing stable sodium pyrouvate and preparing method and use thereof |
| 04/17/2008 | US20080089844 by opening ATP-sensitive potassium channels; circulatory, respiratory, urinary, digestive, reproductive, endocrine, or neurological organs or somatic cells; arrest, protect or preserve the heart during surgery or from reperfusion injury; administering with an adenosine receptor agonist |
| 04/16/2008 | EP1911471A1 Agent for visualizing vitreous body |
| 04/16/2008 | EP1545563B1 Composition and method for use in intestinal cleansing procedures |
| 04/09/2008 | CN101156969A Anti-conglutination material containing calcium ion and carboxymethyl cellulose after operation as well as its preparing method |
| 04/08/2008 | US7354940 2,5-dioxoimidazolidin-4-yl acetamines and analogues as inhibitors of metalloproteinase mmp12 |
| 04/03/2008 | WO2008040002A2 Methods, compositions and articles of manufacture for hif modulating compounds |
| 04/02/2008 | EP1905443A1 Liquid for preventing tissue adhesion and method of preventing tissue adhesion |
| 04/02/2008 | EP1701733B1 Surface protection of exposed biological tissues |
| 03/27/2008 | WO2008034908A2 Use of vitamin d compounds for the prevention of adhesions |
| 03/27/2008 | US20080076712 Before cardiopulmonary bypass surgery or coronary artery bypass grafting; injecting a polypeptide preferential inhibitor of kallikrein, rather than aprotinin |
| 03/27/2008 | US20080075752 Biocompatible polymer scaffold comprising polyhydroxyethyl methacrylate, polycaprolactone-dimethyl acrylate, silicone rubber, or collagen; array of pores having a similar diameter each connected to at least four other pores; promoting angiogenesis aroung implant; medical equipment |
| 03/26/2008 | EP1901786A2 Biomaterials in the form of fibres for use as medical devices in the treatment of wounds, and their production process |
| 03/20/2008 | WO2008032814A1 Aspirin-containing pharmaceutical agent |
| 03/20/2008 | WO2007124447A3 Use of chalcogenides for treating shock and other adverse conditions |
| 03/20/2008 | US20080069859 Method for treating neovascularization and intravitreal implants |
| 03/19/2008 | EP1513545B1 Methods and means to promote gut absorption |
| 03/18/2008 | US7345151 Antagonists specific for denatured collagen and methods of using same |
| 03/18/2008 | CA2335928C Compositions biphasiques injectables, notamment utiles en chirurgies reparatrice et esthetique |
| 03/13/2008 | US20080064637 Before cardiopulmonary bypass surgery or coronary artery bypass grafting; injecting a polypeptide preferential inhibitor of kallikrein, rather than aprotinin |
| 03/13/2008 | US20080063682 treatment of surgical adhesions, keloid; continuously controlled release a therapeutic agent in combination with a fucoidan |
| 03/12/2008 | EP1897553A1 Inhibitor of stem cell proliferation and uses thereof |
| 03/12/2008 | EP1768602A4 Combination drug therapy for reducing scar tissue formation |
| 03/12/2008 | CN101138635A Fibrin glue vasodilation agent sustained-release long-acting composition |
| 03/11/2008 | US7342032 Psychiatric and neurological disorders; cannabinoid (cb1) receptor; such as 4-(4-Chlorophenyl)-5-(2,4-dichlorophenyl)-N-(1-piperidinyl)thiazole-2-carboxamide |
| 03/06/2008 | US20080058469 Adhesion Preventive Material |
| 03/06/2008 | US20080057103 Methods of using medical devices for controlled drug release |
| 03/06/2008 | US20080057102 drug elution rate controlling matrix is disposed within the pores such that substantially none of the matrix protrudes from the pores and the porous body protects the matrix material of biocompatible, biodegradable natural or synthetic polymer; stents, endoprosptheses, catheters, dental implants |
| 03/05/2008 | EP1893230A2 Use of modified factor vii for treating bleeding |
| 03/04/2008 | US7340299 Methods of indirectly stimulating the vagus nerve to achieve controlled asystole |
| 02/28/2008 | US20080050421 Methods for reducing neovascularization or edema |
| 02/28/2008 | US20080050420 Methods for reducing neovascularization or edema |
| 02/27/2008 | EP1021084B9 Solution and process for resuscitation and reparation of ischemically damaged tissue |
| 02/27/2008 | CN101129634A Ducksmeat yinqiao water |
| 02/21/2008 | WO2008019434A1 The use of growth factors in a method of improving fat-graft survival |
| 02/21/2008 | US20080045527 Immunomodulating Heterocyclic Compounds |
| 02/21/2008 | US20080045484 Use of Aromatase Inhibitors for Endometrial Thinning in Preparation for Surgical Procedures on the Endometrial Cavity and Uterus |
| 02/20/2008 | EP1889639A2 Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents, for producing long lasting antineoplastic agents |
| 02/20/2008 | EP1888049A2 Localized delivery of cardiac inotropic agents |
| 02/20/2008 | EP1383747B1 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf) |
| 02/20/2008 | CN101128578A Method of inducing differentiation of skeletal muscle cell |
| 02/20/2008 | CN101125149A Ophthalmic operating special-purpose colored perfusate |
| 02/19/2008 | US7332498 N-(3-amino-propyl)-N-[1-(3-benzyl-4-oxo-3,4-dihydro-pyrido[2,3-d]pyrimidin-2-yl)-2-methyl-propyl]-4-methyl-benzamide; kinesin spindle protein inhibitor; cell division, mitosis phase arrest; antiproliferative and antiinflammation agent, hyperplasias, restenosis, cardiac hypertrophy, autoimmune disorders |
| 02/19/2008 | CA2273240C Compositions and methods for treating or preventing inflammatory diseases |
| 02/19/2008 | CA2220505C N,o-carboxymethylchitosan for prevention of surgical adhesions |
| 02/14/2008 | US20080039459 Phosphoinositide 3-kinase inhibitor compounds and methods of use |
| 02/14/2008 | US20080039363 administering angiotensinogen; pluripotent stem cell transplantation; for supporting bone marrow transplantation, and promoting megakaryocyte production and mobilization and platelet production; improved leukocyte production |
| 02/14/2008 | US20080038376 Anti-cancer composition and method for using the same |
| 02/14/2008 | US20080038352 Electroprocessed Collagen and Tissue Engineering |
| 02/14/2008 | US20080038312 Insertable or implantable medical devices suitable for gene therapy regimens |
| 02/13/2008 | CN100367941C Formulation, which can be administered gastrointestinally, and uses thereof |
| 02/07/2008 | US20080031859 Central nervous system neural progenitor cell which induces synapse-forming neurons in the spinal cord |
| 02/07/2008 | US20080031854 Thiolated macromolecules and methods of making and using thereof |
| 02/06/2008 | CN101117340A Ruthenium-anthraquinone conjugates, preparation method thereof and application for optical power therapeutic photosensitizer |
| 02/05/2008 | US7326412 Fibrinogen plus a non-plasmin-acting fibrinolysis inhibitor for the reduction or prevention of adhesion formation |
| 01/31/2008 | US20080026998 Human kunitz-type inhibitor with enhanced antifibrinolytic activity |
| 01/30/2008 | CN101112440A Medicinal composition for treating intestinal obstruction and method for preparing the same |
| 01/30/2008 | CN100364971C Pyrrolidine-2-ones as factor Xa inhibitors |
| 01/29/2008 | US7323474 Pyridine derivatives inhibiting angiogenesis and/or VEGF receptor tyrosine kinase |
| 01/29/2008 | US7323163 Film-forming compositions and methods |
| 01/29/2008 | US7323118 Composition of hypochlorous acid and its applications |
| 01/24/2008 | US20080019955 Surface Protection of Exposed Biological Tissues |
| 01/10/2008 | WO2008005277A1 Everolimus/pimecrolimus-eluting implantable medical devices |
| 01/03/2008 | US20080003254 Systems and methods for delivering a rapamycin analog that do not inhibit human coronary artery endothelial cell migration |
| 01/03/2008 | US20080003220 Buffering agents for biopharmaceutical formulations |
| 01/03/2008 | CA2839595A1 Caspase-8 and inflammation, infection and wound healing |
| 01/02/2008 | CN100358527C Formulation of amino acids and riboflavin useful to reduce toxic effects of cytotoxic chemotherapy |
| 12/27/2007 | WO2007148714A1 Implant using rifamycin derivative |
| 12/27/2007 | WO2007148713A1 Drug for treating vascular disease or drug for controlling cell proliferation comprising rifamycin derivative as the active ingredient |
| 12/27/2007 | US20070299135 Compositions for Use in Surgery |
| 12/27/2007 | US20070298076 Method for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor |
| 12/26/2007 | EP1870105A1 Use of fucans in the treatment of psoriasis |
| 12/25/2007 | US7312230 Carboxylic acid derivatives as IP antagonists |
| 12/21/2007 | CA2690878A1 Biodegradable polymer adhesion barriers |
| 12/20/2007 | US20070293586 Novel propofol composition comprising ascorbic acid or pharmaceutically acceptable salts thereof |
| 12/20/2007 | US20070293513 Cristalline and amorphous form of a triazolo (4,5-d) pyridimine compound |
| 12/19/2007 | EP1438976B1 Polyfunctional biocompatible hydrogel and method for the production thereof |
| 12/18/2007 | US7310552 Apparatus for indirectly stimulating the vagus nerve with an electrical field |
| 12/13/2007 | US20070287662 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress |
| 12/13/2007 | US20070287173 Therapeutic polypeptide with prolonged shelf-life and increased half life for use in treatment of cell proliferative, cardiovascular, inflammatory and autoimmune disorders |
| 12/13/2007 | US20070286850 Mevalonate Kinase |
| 12/13/2007 | US20070286840 generation of NO from a C-based diazeniumdiolate that is covalently attached to a phenyl-containing polymer( polystyrene homo or copolymer, polyethyene terephthalate, polyamides etc.) without the possibility to form nitrosamines; of vascular stents, vascular grafts, catheters, wound dressings, bandages |
| 12/06/2007 | WO2007137321A1 Improved tissue maintenance |
| 12/06/2007 | US20070282014 Hydroxyethylstarch |
| 12/06/2007 | US20070280989 Compositions and Methods for Stem Cell Expansion and Differentiation |
| 12/06/2007 | US20070280883 Methods for Carbon Isotope Labeling Synthesis of Ketones and Amines by Suzuki Coupling Reactions Using Carbon-Isotope Monoxide |
| 12/06/2007 | CA2688028A1 Improved tissue maintenance |
| 12/05/2007 | EP1862476A2 RGD-enriched gelatine-like proteins with enhanced cell binding |
| 12/05/2007 | EP1539196B1 Vitreoretinal tamponades based on fluorosilicone fluids |
| 12/04/2007 | US7303758 From a two-layered polymeric matrix including incompatible polymers, the top layer controls elution rate of said drugs; e.g. fluoropolymer layer covered with a polyacrylate top layer; stents, anastomotic devices |
| 11/29/2007 | US20070274946 Tolerance to Graft Prior to Thymic Reactivation |
| 11/28/2007 | CN101077347A Multifunctional membrane used for glaucoma post-operation and preparation method thereof |
| 11/21/2007 | EP1857544A1 Pluripotent stem cell derived from cardiac tissue |
| 11/21/2007 | EP1301500B1 Nitrosated and nitrosylated taxanes, compositions and methods of use |
| 11/20/2007 | US7297681 For use in therapy of growth metabolic disorders |
| 11/15/2007 | WO2007129618A1 Inhibitor of neutrophil activation/migration factor and use thereof |